Asunto(s)
Dermatología , Neoplasias , Enfermedades de la Piel , Humanos , Omalizumab/uso terapéutico , Inhibidores de Puntos de Control Inmunológico/efectos adversos , Estudios Retrospectivos , Enfermedades de la Piel/inducido químicamente , Neoplasias/tratamiento farmacológico , Prurito/inducido químicamenteRESUMEN
African tick-bite fever (ATBF), a tickborne disease endemic in rural areas of sub-Saharan Africa and the West Indies caused by Rickettsia africae, has been recognized as an emerging health problem in recent years. ATBF has been reported as the second most commonly documented etiology of fever, after malaria, in travelers who return ill from sub-Saharan Africa. Most cases reported in the literature occurred in middle-aged adults, so the incidence of ATBF in children is unclear. We report a cluster of three cases of ATBF that occurred in children ages 7 to 16 years after returning from a game-hunting safari in South Africa.
Asunto(s)
Antibacterianos/uso terapéutico , Doxiciclina/uso terapéutico , Rickettsiosis Exantemáticas/diagnóstico , Adolescente , Niño , Fiebre/etiología , Humanos , Masculino , Rickettsia , Úlcera Cutánea/etiología , Sudáfrica , Rickettsiosis Exantemáticas/tratamiento farmacológico , ViajeRESUMEN
Trichodysplasia spinulosa (TS) is a rare entity, characterized by a follicular digitate keratosis predominantly affecting the face and variable degrees of hair loss, most severely facial hair, that occurs in immunosuppressed individuals, and is considered to be a viral infection caused by a human polyomavirus, the "TS-associated polyomavirus." Histologically it is characterized by hair follicles with excessive inner root-sheath differentiation and intraepithelial viral inclusions. Correlation of these findings with clinical features is required for diagnosis. Treatment with antiviral agents appears to be the most effective. We report the occurrence of TS in a 20-month-old girl with multivisceral transplantation due to short-bowel syndrome secondary to intestinal atresia and gastroschisis. The patient was treated with cidofovir 1% cream, with significant improvement and without any adverse effects. We describe the youngest patient, to our knowledge, with TS.